Voloridge Investment Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Voloridge Investment Management's DGX Position: Q4 2023 in Review
Voloridge Investment Management sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 2,846 shares — an estimated $347K sold.
Voloridge Investment Management first reported a position in DGX in Q2 2015 and held it in 17 quarters. The position peaked at $40.4M in Q1 2021. 826 funds tracked by Wall St. Rank hold DGX as of Q4 2023.
- Voloridge Investment Management reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
- Voloridge Investment Management sold 2,846 Quest Diagnostics shares in Q4 2023, an estimated $347K.
- Voloridge Investment Management first reported a position in Quest Diagnostics in Q2 2015 and held it in 17 quarters.
- Voloridge Investment Management's Quest Diagnostics position peaked at $40.4M in Q1 2021.
- 826 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.
Based on Voloridge Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.